Clinical trial
US Inhaled Insulin Therapeutic Choice Questionnaire Study
NCT00139763 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00139763 |
|---|---|
| Title | US Inhaled Insulin Therapeutic Choice Questionnaire Study |
| Official title | A US Randomized Questionnaire-Based Trial Assessing The Impact Of The Availability Of Inhaled Insulin On Therapeutic Choice In Patients With Suboptimally Controlled Type 2 Diabetes |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Procedure |
| Interventions | Educational Materials |
| Enrollment | 740 |
| Start date | Jul 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | Mar 19, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: